arginas
arg
induc
nitric
oxid
synthas
ino
import
regul
immun
function
metabolit
previou
studi
reveal
express
arg
increas
express
ino
reduc
serum
peripher
blood
mononuclear
cell
human
immunodefici
viru
hiv
infect
patient
one
import
immun
organ
hiv
replic
site
whether
similar
chang
present
lymph
node
follow
hiv
infect
remain
elucid
investig
present
studi
collect
lymph
node
blood
specimen
hivinfect
patient
measur
express
level
arg
ino
immunohistochemistri
fluoresencebas
flow
cytometri
compar
control
subject
without
hiv
infect
patient
hiv
significantli
higher
express
level
arg
lymph
node
higher
frequenc
arg
cell
cell
blood
lymph
node
result
contrari
ino
correspond
compart
express
level
arg
lymph
node
blood
neg
associ
peripher
cell
count
posit
associ
viral
load
howev
express
level
ino
lymph
node
blood
posit
associ
peripher
cell
count
neg
associ
viral
load
result
show
alter
express
level
arg
ino
peripher
cell
peripher
node
hiv
infect
patient
associ
diseas
progress
patient
result
indic
potenti
therapeut
strategi
delay
diseas
progress
regul
manipul
express
level
arg
ino
patient
infect
hiv
present
trend
human
immunodefici
viru
hiv
infect
remain
high
level
worldwid
treatment
hivacquir
immun
defici
syndrom
aid
challeng
although
highli
activ
antiretrovir
therapi
haart
significantli
reduc
number
new
case
hiv
infect
improv
prognosi
patient
hivaid
previou
decad
signific
advanc
understand
pathogenesi
hivaid
howev
certain
aspect
remain
elucid
includ
function
chang
immun
organ
exampl
lymph
node
follow
hiv
infect
damag
caus
hiv
infect
gradual
multistag
end
aid
chronic
hiv
infect
may
progress
compromis
immun
function
loss
peripher
lymphocyt
due
continu
sever
injuri
marker
aid
progress
major
caus
immun
dysfunct
hivaid
howev
hiv
infectioninduc
chronic
inflamm
reduct
number
lymphocyt
fulli
explain
immun
dysfunct
occur
progress
hivaid
previou
studi
shown
metabol
larginin
one
import
mechan
underli
regul
immun
respons
larginin
substrat
arginas
arg
includ
arg
ii
nitric
oxid
synthas
no
includ
arg
ii
hydrolyz
larginin
lornithin
urea
lornithin
metabol
polyamin
involv
prolifer
differenti
cell
no
catalyz
convers
larginin
citrullin
nitric
oxid
import
effector
regul
immun
system
arg
releas
immun
cell
includ
polymorphonuclear
neutrophil
inflamm
also
involv
inflammatori
respons
induc
no
ino
express
varieti
immun
cell
studi
report
arg
regul
bioavail
larginin
involv
certain
immuneassoci
patholog
process
includ
inflammationtrigg
immun
dysfunct
immun
evas
cancer
cell
fibrosi
immunosuppress
immun
respons
infecti
agent
competitor
arg
ino
hydrolyz
larginin
import
destroy
parasit
bacteria
virus
cancer
cell
well
vascular
dilat
previou
studi
reveal
express
arg
increas
express
ino
reduc
serum
peripher
blood
mononuclear
cell
pbmc
patient
hiv
howev
express
level
arg
ino
peripher
lymph
node
ln
hivinfect
patient
remain
fulli
elucid
present
studi
express
level
arg
ino
peripher
ln
peripher
cell
investig
aim
elucid
role
arg
ino
progress
hivaid
inform
consent
obtain
prior
surgic
resect
ln
studi
approv
ethic
committe
hospit
pla
beij
china
peopl
hospit
nan
nan
china
ln
routin
collect
surgeri
neck
armpit
groin
process
examin
time
ml
peripher
blood
collect
patient
control
group
hivaid
diagnos
accord
guidelin
use
antiretrovir
agent
adult
adolesc
usdhh
patient
divid
asymptomat
group
aid
group
addit
peripher
superfici
biopsi
ln
collect
neck
armpit
subject
without
hiv
infect
recruit
hospit
pla
process
patholog
examin
two
experienc
pathologist
exclus
criteria
includ
presenc
cancer
infect
autoimmun
diseas
presenc
reactiv
hyperplasia
confirm
subject
serv
control
addit
peripher
blood
collect
healthi
control
subject
absolut
cell
count
peripher
blood
tcell
count
determin
use
multitest
imk
lymphocyt
kit
cat
bd
bioscienc
san
jose
ca
usa
trucount
tube
cat
bd
bioscienc
whole
blood
collect
incub
antibodi
min
room
temperatur
bd
multitest
imk
kit
lysi
solut
subsequ
ad
tube
min
incub
room
temperatur
cell
count
use
flow
cytometri
facscanto
ii
bd
bioscienc
detect
viral
load
blood
process
within
h
postcollect
centrifug
min
x
g
plasma
separ
follow
hiv
rna
extract
use
roch
coba
ampliprepcoba
taqman
automat
analysi
system
roch
diagnost
basel
switzerland
usa
viral
load
quantit
measur
use
roch
coba
ampliprepcoba
taqman
test
kit
version
roch
diagnost
accord
manufactur
instruct
separ
mononuclear
cell
ln
ln
minc
filter
mesh
filter
pore
size
shanghai
shanghai
china
filtrat
retain
layer
onto
plu
cat
ge
healthcar
littl
chalfont
uk
centrifug
x
g
min
obtain
mononuclear
cell
includ
lymphocyt
detect
express
level
arg
ino
use
streptomycin
avidinbiotinperoxidas
complex
immunohistochem
analysi
ln
collect
fix
paraformaldehyd
beij
chemic
work
beij
china
embed
paraffin
leica
biosystem
nussloch
germani
section
briefli
slide
wash
xylen
zsgbbio
beij
china
remov
paraffin
rehydr
serial
dilut
alcohol
beij
chemic
work
follow
wash
phosphatebuff
salin
pb
ph
zsgbbio
treat
slide
place
citrat
buffer
ph
zsgbbio
heat
microwav
oven
min
retriev
antigen
treat
h
beij
chemic
work
methanol
beij
chemic
work
inactiv
endogen
peroxidas
treat
fetal
bovin
serum
invitrogen
thermo
fisher
scientif
waltham
usa
block
nonspecif
bind
section
incub
overnight
antibodi
cat
monoclon
mous
immunoglobulin
ig
clone
dilut
r
system
minneapoli
mn
usa
antiino
antibodi
cat
rabbit
polyclon
dilut
abcam
cambridg
uk
wash
three
time
pb
follow
incub
horseradish
peroxidas
hrp
conjug
secondari
antibodi
cat
plu
hrp
rabbit
dab
bulk
kit
cat
plu
hrp
dab
mous
bulk
kit
golden
bridg
intern
bothel
wa
usa
min
section
incub
zsgbbio
visual
express
arg
ino
posit
cell
contain
brown
granul
neg
control
ln
hivinfect
patient
phosphatebuff
salin
use
place
primari
antibodi
ln
section
subject
without
hiv
treat
primari
antibodi
also
serv
control
determin
imag
captur
specimen
evalu
semiquantit
two
pathologist
blindedmann
frequenc
posit
cell
total
cell
magnif
score
follow
stain
intens
background
level
score
follow
stain
light
yellow
yellowbrown
brown
score
serv
measur
target
protein
express
final
score
product
two
score
neg
weakli
posit
posit
strongli
posit
slide
mount
gum
examin
captur
use
olympu
microscop
olympu
corp
tokyo
japan
nikon
digit
camera
system
nikon
corp
tokyo
japan
studi
comparison
evalu
five
field
randomli
select
per
section
magnif
detect
express
level
arg
ino
use
flow
cytometri
mononuclear
cell
peripher
blood
ln
ad
three
tube
cellstub
incub
isothiocyan
cat
monoclon
mous
clone
bd
bioscienc
chlorophyl
protein
cat
monoclon
mous
clone
bd
bioscienc
permeabil
use
cytofixcytoperm
fixationpermeabil
kit
bd
bioscienc
subsequ
three
tube
arg
ino
isotyp
control
divid
three
group
either
cat
monoclon
mous
clone
r
system
antiino
antibodi
cat
rabbit
polyclon
abcam
isotyp
control
antibodi
cat
monoclon
mous
clone
r
system
ad
one
tube
contain
peripher
blood
mononuclear
cell
one
tube
contain
ln
mononuclear
cell
buffer
kit
use
wash
cell
ino
group
incub
goat
antirabbit
iggallophycocyanin
cat
polyclon
abcam
min
fix
paraformaldehyd
h
flow
cytometri
perform
within
h
use
facscanto
ii
flow
cytomet
bd
bioscienc
flowjo
softwar
version
flowjo
llc
ashland
canada
use
analyz
data
lymphocyt
gate
base
forward
scattersid
scatter
separ
cell
cell
express
level
arg
ino
analyz
statist
analysi
statist
analysi
perform
use
spss
version
spss
inc
chicago
il
usa
continu
variabl
compar
use
analysi
varianc
anova
oneway
anova
use
evalu
differ
among
group
noncontinu
variabl
compar
use
mannwhitney
u
test
two
group
kruskalw
h
nonparametr
test
among
group
correl
evalu
use
pearson
spearman
correl
analysi
p
consid
indic
statist
signific
differ
order
determin
chang
express
level
arg
ino
ln
follow
hiv
infect
present
studi
firstli
evalu
express
level
arg
ino
peripher
ln
situ
use
immunohistochemistri
result
show
arg
predominantli
express
cytoplasm
level
express
vari
among
group
neg
strongli
posit
control
group
fig
express
arg
weakli
posit
posit
wherea
express
level
arg
patient
group
fig
almost
posit
strongli
posit
contrast
express
ino
exhibit
opposit
trend
chang
express
arg
express
ino
posit
control
group
fig
posit
weakli
posit
neg
patient
group
fig
f
taken
togeth
result
immunohistochem
analys
show
patient
group
express
level
arg
significantli
higher
compar
control
group
p
fig
wherea
express
level
ino
significantli
lower
compar
control
group
p
fig
signific
differ
observ
asymptomat
aid
group
p
express
level
arg
ino
peripher
cell
patient
hivaid
subsequ
present
studi
detect
frequenc
arg
ino
cell
cell
isol
peripher
blood
sampl
ln
tissu
asymptomat
patient
symptomat
patient
aid
control
flow
cytometri
perform
assess
chang
express
level
arg
ino
lymphocyt
subset
asymptomat
symptomat
aid
group
frequenc
cell
posit
arg
peripher
blood
significantli
higher
compar
control
p
frequenc
cell
posit
ino
peripher
blood
significantli
lower
compar
control
p
fig
addit
frequenc
cell
posit
arg
peripher
blood
significantli
higher
compar
control
p
posit
ino
peripher
blood
significantli
lower
compar
control
p
fig
howev
frequenc
similar
patient
group
p
analog
result
obtain
peripher
ln
two
patient
group
frequenc
cell
posit
arg
peripher
ln
significantli
higher
p
posit
ino
significantli
lower
p
compar
control
fig
frequenc
posit
arg
peripher
ln
cell
significantli
higher
p
posit
ino
significantli
lower
p
compar
control
fig
frequenc
differ
significantli
among
patient
group
p
correl
express
level
arg
ino
cell
count
cell
count
import
clinic
indic
progress
aid
investig
effect
arg
ino
progress
aid
associ
peripher
blood
cell
count
frequenc
cell
cell
posit
arg
ino
examin
peripher
blood
peripher
ln
protein
express
level
arg
ino
peripher
ln
also
evalu
shown
fig
peripher
cell
count
neg
associ
frequenc
cell
cell
posit
arg
peripher
blood
p
p
respect
peripher
ln
p
respect
howev
peripher
cell
count
posit
associ
frequenc
ino
cell
cell
peripher
blood
p
p
respect
peripher
ln
p
p
respect
fig
correl
express
level
arg
ino
viral
load
viral
load
anoth
import
indic
use
evalu
sever
aid
therefor
present
studi
also
evalu
associ
viral
load
frequenc
cell
cell
posit
arg
ino
peripher
blood
ln
associ
protein
express
level
arg
ino
peripher
ln
also
examin
shown
fig
viral
load
posit
associ
frequenc
arg
posit
cell
cell
peripher
blood
p
respect
peripher
ln
p
p
respect
howev
viral
load
neg
associ
frequenc
ino
posit
cell
cell
peripher
blood
p
p
respect
peripher
ln
p
p
respect
term
protein
express
level
peripher
cell
count
neg
associ
protein
express
arg
p
fig
viral
load
posit
associ
protein
express
arg
ln
p
fig
furthermor
peripher
cell
count
posit
associ
express
ino
p
fig
ln
viral
load
neg
associ
protein
express
ino
ln
p
fig
one
import
amino
acid
larginin
exert
varieti
biolog
effect
involv
synthesi
protein
urea
creatin
metabol
human
bodi
via
arg
pathway
ino
pathway
differ
effect
immun
function
mention
express
arg
increas
express
ino
reduc
serum
pbmc
hivinfect
patient
ln
import
site
prolifer
differenti
develop
lymphocyt
crucial
mainten
normal
immun
function
chang
metabol
ln
larginin
remain
fulli
elucid
patient
hiv
infect
therefor
present
studi
immunohistochemistri
flow
cytometri
use
detect
express
level
arg
ino
peripher
cell
ln
result
show
compar
control
asymptomat
symptomat
hiv
infect
patient
exhibit
increas
frequenc
arg
posit
cell
cell
peripher
blood
ln
increas
protein
express
level
arg
ln
addit
frequenc
arg
posit
cell
cell
peripher
blood
ln
protein
express
level
arg
ln
neg
associ
peripher
cell
count
posit
correl
hiv
load
contrast
frequenc
ino
posit
cell
cell
peripher
blood
ln
protein
express
level
ino
decreas
ln
hivinfect
patient
compar
control
furthermor
frequenc
ino
posit
cell
cell
peripher
blood
ln
protein
express
level
ino
ln
posit
associ
peripher
cell
count
neg
associ
hiv
load
argininemedi
metabol
larginin
hydrolyz
urea
ornithin
ornithin
precursor
polyamin
indispens
prolifer
cell
parasit
least
two
subtyp
arginas
identifi
mammal
cytoplasm
arg
mitochondri
arg
ii
involv
reaction
although
arg
import
urea
cycl
liver
addit
role
larginin
metabol
arg
import
immun
system
function
inhibit
synthesi
induc
fibrosi
tissu
regener
arg
also
involv
multipl
inflammatori
diseas
essenti
normal
cell
function
myeloid
cell
arg
downregul
express
inhibit
express
cell
cycl
regulatori
protein
cell
cycl
regulatori
proteindepend
kinas
lead
inhibit
cell
activ
subsequ
suppress
immun
function
cell
mechan
import
immunosuppress
certain
inflammationassoci
condit
helicobact
pylori
toxoplasma
gondii
may
use
arginin
induc
inflammationassoci
immun
suppress
lead
immun
evas
no
pathway
larginin
metabol
ino
citrullin
import
destruct
cancer
cell
virus
bacteria
parasit
regul
varieti
immun
cell
no
three
isoform
includ
two
constitut
isoform
neural
no
endotheli
no
one
induc
isoform
ino
constitut
no
predominantli
involv
physiolog
synthesi
regul
differ
physiolog
function
activ
depend
howev
ino
predominantli
involv
immun
regul
proinflammatori
respons
larginin
substrat
arg
ino
therefor
high
express
level
arg
may
deplet
larginin
increas
level
ornithin
polyamin
requir
prolifer
cell
parasit
reduct
larginin
caus
decreas
ino
pathway
competit
arg
ino
pivot
immun
respons
infect
determin
cours
infect
exampl
periton
macrophag
rat
differ
mice
resist
toxoplasma
gondi
infect
natur
resist
ascrib
increas
express
activ
ino
reduc
activ
arg
rat
periton
macrophag
compar
mous
periton
macrophag
hiv
infect
significantli
reduc
number
cell
particularli
aid
phase
polyamin
metabol
product
larginin
arg
essenti
substrat
cell
prolifer
increas
arg
peripher
blood
ln
increas
number
cell
follow
hiv
infect
result
present
studi
indic
neg
correl
express
arg
peripher
cell
ln
peripher
cell
count
suggest
express
arg
increas
compens
reduct
cell
howev
larginin
regul
transcript
ino
concentrationdepend
manner
arg
significantli
reduc
level
larginin
lead
reduct
ino
synthesi
thu
increas
express
level
arginduc
reduct
ino
synthesi
lead
reduct
product
releas
macrophag
import
role
innat
immun
reduc
synthesi
may
directli
impair
innat
factor
contribut
signific
increas
hiv
replic
compromis
antiinfect
abil
aid
phase
result
develop
opportunist
infect
reduct
due
competit
arg
ino
also
import
pathogenesi
varieti
diseas
includ
atherosclerosi
hypertens
myocardi
ischemiareperfus
injuri
diabet
allerg
asthma
inflammatori
diseas
thu
import
metabol
enzym
affect
synthesi
mechan
inhibit
progress
diseas
inhibit
arg
activ
function
interfer
remain
area
increas
interest
certain
synthet
natur
compound
inhibit
arg
investig
diseas
therapi
certain
small
molecul
inhibitor
arg
show
potenti
treatment
diabet
allerg
inflamm
schistosoma
mansoni
parasit
infect
time
evid
rat
show
arg
may
serv
biomark
diagnosi
type
diabet
result
present
studi
also
show
hiv
load
peripher
cell
independ
associ
express
level
arg
ino
thu
although
haart
may
exert
therapeut
effect
reduc
express
arg
increas
express
ino
arg
inhibitor
may
use
adjuv
therapi
treat
hiv
infect
particularli
aid
improv
immun
function
prevent
opportunist
infect
inhibit
viral
replic
addit
correl
suggest
express
level
arg
ino
peripher
cell
may
use
diagnost
predict
progress
hiv
infect
conclus
present
studi
suggest
abnorm
express
level
arg
ino
peripher
blood
ln
cell
may
contributor
compromis
immun
patient
hiv
respons
signific
elev
viral
load
aid
phase
appear
opportunist
infect
addit
express
level
arg
ino
cell
peripher
blood
ln
may
potenti
paramet
predict
diseas
progress
express
level
arg
ino
peripher
blood
ln
cell
found
correl
hiv
load
cell
count
